SCIENTIFIC PROGRAM
XIII Brazilian Radiotherapy Society Congress
06/22 (Wednesday)   
20:00 - 20:30
Opening ceremony
   Dr. CARLOS MANOEL MENDONÇA DE ARAÚJO (RJ) - President of the Congress
   Dr. LUIZ AUGUSTO MALTONI JÚNIOR (RJ) - Director of INCA
21:00
Opening reception with cocktail
06/23 (Thursday)   
08:30 - 09:00
Opening conference: Recent advances in the adjuvant treatment of breast cancer
Moderator: CÉLIA MARIA PAIS VIÉGAS (RJ)
Speaker: Dra. YOULIA M KIROVA (FRANÇA)
09:00 - 10:00
Debate: Controversies in breast cancer
Moderator: Dr. MIGUEL TORRES TEIXEIRA LEITE (MG)
09:00 - 09:10 Radiotherapy in patients with prosthesis : Indications and cautions
Dra. LILIAN DANTONINO FARONI (RJ)
09:10 - 09:20 Radiotherapy in patients with prosthesis : Risks
EDUARDO MARTELLA (SP)
09:20 - 09:30 Radiotherapy post adenomastectomy : No
Dr. MAURICIO AUGUSTO SILVA MAGALHAES COSTA (RJ)
09:30 - 09:40 Radiotherapy post adenomastectomy : Yes
Dra. YOULIA M KIROVA (FRANÇA)
09:40 - 10:00 Debate with the speakers
10:00 - 10:30
Coffee break
10:30 - 11:00
Conference: Level of evidence interpretation in Radiation Oncology. Is it manageable?
President: Dr. MARCOS DUARTE DE MATTOS (SP)
Speaker: Dr. LUIS SOUHAMI (CANADA)
11:00 - 12:30
Round table: The contributions of modern radiotherapy
Moderator: Dr. CARLOS MANOEL MENDONÇA DE ARAÚJO (RJ)
11:00 - 11:20 True Beam: A new era in radiotherapy?
Dr. SHALOM KALNICKI (USA)
11:20 - 11:40 CyberKnife: The Ideal Radiosurgery Tool
Dr. BRIAN T. COLLINS, M.D. (USA)
11:40 - 12:00 Elekta VMAT - A winning combination for faster delivery of VMAT prescriptions
DR. FRANK LOHR (ALEMANHA)
12:00 - 12:20
PEDRO PEREIRA
12:20 - 12:30 Questions and discussion
12:30 - 14:00
LUNCH
14:00 - 16:00
Debate: Controversies in prostate cancer
Moderator: Dr. JOÃO LUÍS FERNANDES DA SILVA (SP)
14:00 - 14:15 Radiotherapy in low and intermediate risks: Brachytherapy
Dr. MARTIN E. KEISCH (USA)
14:15 - 14:30 Radiotherapy in low and intermediate risks: External radiotherapy
Dr. JEFF M. MICHALSKI (USA)
14:30 - 14:40 Hormonotherapy in intermediate risk: Advantages
Dr. ÓREN SMALETZ (SP)
14:40 - 14:50 Hormonotherapy in intermediate risk: Disavantages
Dr. MADHUR GARG (USA)
14:50 - 15:05 High risk treatment: surgery
Dr. LUIZ RENATO MUGLIA (RJ)
15:05 - 15:20 High risk treatment: radiotherapy
Dr. JEFF M. MICHALSKI (USA)
15:20 - 15:35 Normal organs restrictions are defined? - YES
Dr. MADHUR GARG (USA)
15:35 - 15:50 Normal organs restrictions are defined? - NO
Dr. SÉRGIO LUIS FARIA (CANADÁ)
15:50 - 16:00 Debate with the speakers
16:00 - 16:30
Coffee break
16:30 - 17:00
Conference: Hypofractionated radiotherapy in prostate cancer. Where are we?
President: Dr. SÉRGIO CARLOS BARROS ESTEVES (SP)
Conferencist: Dr. JEFF M. MICHALSKI (USA)
17:00 - 17:30
Conference: Accidents in radiotherapy. How to avoid them?
President: ANDRE MOZART DE MIRANDA VIEIRA (SP)
Conferencist: Prof. CARLOS EDUARDO DE ALMEIDA (RJ)
17:30 - 18:00
Conference: Partial breast radiotherapy. Indications and modalities.
President: Dr. AROLDO DE PAIVA FERREIRA BRAGA FILHO (RS)
Conferencist: Dr. MARTIN E. KEISCH (USA)
06/24 (Friday)   
08:30 - 09:00
Current status of radiotherapy in the treatment of soft tissue sarcomas
President: Dr. NEIRO WAECHTER DA MOTTA (RS)
Conferencist: Dr. MARTIN E. KEISCH (USA)
09:00 - 10:10
Scientific session
Dr. EDUARDO WELTMAN (SP)
PAULO CESAR VENTURA CANARY (RJ)
Dr. SÉRGIO LUIS FARIA (CANADÁ)
Coordinator: Dr. ROBERTO ARAUJO SEGRETO (SP)
10:10 - 10:30
Coffee break
10:30 - 12:00
Round table: From the laboratory to the clinical practice
Moderator: Dr. ÓREN SMALETZ (SP)
10:30 - 10:55 Influence of radiobiology in radiotherapy clinical decisions
Dra. HELENA REGINA COMODO SEGRETO (SP)
10:55 - 11:20 Combined treatment of radiotherapy and chemotherapy
Dr. MARIO ALBERTO DANTAS LOURES DA COSTA (RJ)
11:20 - 11:45 Perspectives and interaction of new drugs with radiation
Dr. CARLOS GIL MOREIRA FERREIRA (RJ)
11:45 - 12:00 Questions and discussion
12:00 - 14:00
LUNCH
14:00 - 15:00
Assembly and nomination of the new directive of SBRT
Dr. CARLOS MANOEL MENDONÇA DE ARAÚJO (RJ)
15:00 - 16:00
Forum of debate: HPV and cancer
Moderator: Dra. HELOISA DE ANDRADE CARVALHO (SP)
15:00 - 15:30 HPV in head and neck and cervix cancer. Impact and vaccination recommendations
Dra. LAURA CRISTINA SICHERO VETTORAZZO (SP)
15:30 - 15:50 Incorporation of HPV Vaccine through the SUS from the INCA vision
Dr. CLAUDIO POMPEIANO NORONHA (RJ)
15:50 - 16:00 Debate with the speakers
16:00 - 16:30
Coffee break
16:30 - 17:30
Round table: Round table: Head and Neck tumors revision
Moderator: FELIPE ERLICH (RJ)
16:30 - 16:50 Current status of chemotherapy in the combined treatment
Dr. DANIEL HERCHENHORN (RJ)
16:50 - 17:20 IMRT, IGRT and adaptive planning in head and neck
Dr. MADHUR GARG (USA)
17:20 - 17:30 Questions and discussion
06/25 (Saturday)   
08:30 - 09:30
Round table debates: High technology radiotherapy
Moderator: Dr. WLADIMIR NADALIN (SP)
08:30 - 08:45 When the high technology brings clinical benefits
Dr. SHALOM KALNICKI (USA)
08:45 - 09:00 How to balance the new and the traditional
Dr. SÉRGIO LUIS FARIA (CANADÁ)
09:00 - 09:15 High technology radiotherapy cautions
Dr. FABIO LUIS BIAGINI CURY (CANADÁ)
09:15 - 09:30 Debate with the speakers
09:30 - 10:00
Conference: Recommendations in the treatment of brain metastasis
President: Dr. LEONARDO FRIGHETTO (RS)
Conferencist: JONATHAN P. S. KNISELY (USA)
10:00 - 10:30
Coffee break
10:30 - 11:50
Round table: Malignant tumors of CNS
Moderator: Dr. HELIO FERREIRA LOPES (RJ)
10:30 - 10:45 Recent advances of neurosurgery and their benefits
Dr. JANIO NOGUEIRA (RJ)
10:45 - 11:00 Current status of chemotherapy in the management of high grade gliomas
Dr. JACQUES BINES (RJ)
11:00 - 11:15 Radiotherapy with IMRT/VMAT in brain. When there are advantages?
Dr. EDUARDO WELTMAN (SP)
11:15 - 11:30 Radiosurgery for malignant tumors. Is there space?
DR. FRANK LOHR (ALEMANHA)
11:30 - 11:45 Treatment planning with functional resonance and PET. Are there advantages?
Dr. SHALOM KALNICKI (USA)
11:45 - 11:50 Questions and discussion
11:50 - 12:10
Conference: Stereotactic body radiotherapy (SBRT). Current indications and benefits
Moderator: Dr. ROBSON FERRIGNO (SP)
Conferencist: Dr. DAVID ROBERGE (CANADÁ)
12:10 - 14:00
LUNCH
14:00 - 15:30
Debate: Surgery versus radiosurgery in benign tumors
Moderator: Dr. SALOMON BENABOU (SP)
14:00 - 14:15 Vestibular schwannomas: Surgery
Dr. EDUARDO VELLUTINI (SP)
14:15 - 14:30 Vestibular schwannomas: Radiosurgery or fractionated stereotactic radiotherapy
Dr. EDUARDO WELTMAN (SP)
14:30 - 14:45 Pituitary tumors: Surgery
Dr. ARTHUR CUKIERT (SP)
14:45 - 15:00 Pituitary tumors: Radiosurgery or fractionated stereotactic radiotherapy
Dra. ALESSANDRA GORGULHO (USA)
15:00 - 15:15 Meningiomas: Surgery
Dr. JANIO NOGUEIRA (RJ)
15:15 - 15:30 Meningiomas: Radiotherapy
Dr. LUIS SOUHAMI (CANADA)
15:30 - 16:00
Conference: Current treatment of arterious venous ma formation
Moderator: Dr. WILSON JOSÉ DE ALMEIDA JR (RS)
Conferencist: Dra. ALESSANDRA GORGULHO (USA)
16:00
End ceremony and awards
Dr. CARLOS MANOEL MENDONÇA DE ARAÚJO (RJ)